AU2003250828A1 - Immunogenic compositions comprising a xenogenic prostate protein p501s - Google Patents

Immunogenic compositions comprising a xenogenic prostate protein p501s

Info

Publication number
AU2003250828A1
AU2003250828A1 AU2003250828A AU2003250828A AU2003250828A1 AU 2003250828 A1 AU2003250828 A1 AU 2003250828A1 AU 2003250828 A AU2003250828 A AU 2003250828A AU 2003250828 A AU2003250828 A AU 2003250828A AU 2003250828 A1 AU2003250828 A1 AU 2003250828A1
Authority
AU
Australia
Prior art keywords
immunogenic compositions
prostate protein
xenogenic prostate
xenogenic
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003250828A
Other languages
English (en)
Other versions
AU2003250828A8 (en
Inventor
Jean-Pol Cassart
Catherine Marie Ghislaine Gerard
Paul A Hamblin
Remi M Palmantier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Glaxo Group Ltd
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0213364A external-priority patent/GB0213364D0/en
Priority claimed from GB0221689A external-priority patent/GB0221689D0/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Publication of AU2003250828A8 publication Critical patent/AU2003250828A8/xx
Publication of AU2003250828A1 publication Critical patent/AU2003250828A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001193—Prostate associated antigens e.g. Prostate stem cell antigen [PSCA]; Prostate carcinoma tumor antigen [PCTA]; PAP or PSGR
    • A61K39/001194—Prostate specific antigen [PSA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/884—Vaccine for a specifically defined cancer prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003250828A 2002-06-11 2003-06-06 Immunogenic compositions comprising a xenogenic prostate protein p501s Abandoned AU2003250828A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0213364A GB0213364D0 (en) 2002-06-11 2002-06-11 Vaccine
GB0213364.3 2002-06-11
GB0221689.3 2002-09-18
GB0221689A GB0221689D0 (en) 2002-09-18 2002-09-18 Vaccine
PCT/EP2003/006095 WO2003103706A2 (en) 2002-06-11 2003-06-06 Immunogenic compositions

Publications (2)

Publication Number Publication Date
AU2003250828A8 AU2003250828A8 (en) 2003-12-22
AU2003250828A1 true AU2003250828A1 (en) 2003-12-22

Family

ID=29738081

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003250828A Abandoned AU2003250828A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions comprising a xenogenic prostate protein p501s

Country Status (6)

Country Link
US (1) US20060140965A1 (enExample)
EP (1) EP1511513A2 (enExample)
JP (1) JP2006501166A (enExample)
AU (1) AU2003250828A1 (enExample)
CA (1) CA2487907A1 (enExample)
WO (1) WO2003103706A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7901680B2 (en) * 2005-10-19 2011-03-08 Ibc Pharmaceuticals, Inc. Dock-and-lock (DNL) vaccines for cancer therapy
WO2006101503A2 (en) * 2004-06-15 2006-09-28 Centocor, Inc. Method for screening agents against human prostate disease
WO2007002149A2 (en) 2005-06-21 2007-01-04 Cyto Pulse Sciences, Inc. Methods and compositions relating to a vaccine against prostate cancer
KR20250121449A (ko) 2017-03-10 2025-08-12 볼트 쓰레즈, 인크. 재조합 단백질을 고분비 수율로 생산하기 위한 조성물 및 방법
EP3592800A4 (en) * 2017-03-10 2021-01-06 Bolt Threads, Inc. COMPOSITIONS AND METHODS OF PRODUCING HIGHLY SECRETED YIELD OF RECOMBINANT PROTEIN

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046769A1 (en) * 1997-04-11 1998-10-22 Dendreon Corporation Composition and method for inducing an immune response against tumour-related antigens
EP1071333A4 (en) * 1998-03-20 2005-02-23 Genzyme Corp INDUCTION OF IMMUNITY AGAINST TUMOR AUTOANTIGENS
TR200100916T2 (enExample) * 1998-07-14 2002-06-21 Corixa@@Corporation
AU7859900A (en) * 1999-10-04 2001-05-10 Corixa Corporation Compositions and methods for wt1 specific immunotherapy
US20020009455A1 (en) * 2000-04-27 2002-01-24 Ted Lau DNA encoding a novel PROST 03 polypeptide

Also Published As

Publication number Publication date
AU2003250828A8 (en) 2003-12-22
WO2003103706A3 (en) 2004-02-19
JP2006501166A (ja) 2006-01-12
US20060140965A1 (en) 2006-06-29
CA2487907A1 (en) 2003-12-18
EP1511513A2 (en) 2005-03-09
WO2003103706A2 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
AU2003253048A1 (en) Tubulysin conjugates
AUPS266702A0 (en) Improved turbine
PL374534A1 (en) Immunogenic compositions
AU2002236159A1 (en) Immunogenic complex
PL376950A1 (pl) Immunogenna kompozycja
AU2003300960A1 (en) Heteroscopic turbine
AU2003235542A1 (en) Improved turbine
MXPA03006989A (es) Leptina modificada con inmunogenicidad reducida.
AU2002367169A1 (en) Dualstage extraction blower
AU2003264368A8 (en) Glycerol derivative
ZA200500199B (en) Immunogenic conjugates
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
AU2003250828A1 (en) Immunogenic compositions comprising a xenogenic prostate protein p501s
AU2003276846A1 (en) Thrombopoiesis-stimulating proteins having reduced immunogenicity
AU2003201681A1 (en) Ventilators
AU2003231434A1 (en) Turbine
AU2003292197A1 (en) Lna-cpg conjugates
AU2002323935A1 (en) Doll
AU2003246936A1 (en) Improved bib
GB2390533B (en) Undergarment
HK1078261A (en) Antigenic compositions
AU2003278235A1 (en) Reversible envelope
HK1076040A (en) Ghrelin-carrier conjugates
CA94412S (en) Envelope
HK1093434A (en) Immunogenic compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 7, PAGE(S) 1750 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME GLAXOSMITHKLINE BIOLOGICALS S.A., APPLICATION NO. 2003250828, UNDER INID (71) CORRECT THE NAME TO READ GLAXOSMITHKLINE BIOLOGICALS S.A.; GLAXO GROUP LIMITED